A Dark Vector Cognition product

Item 2. PROPERTIES

3K characters. Original on sec.gov · Markdown

Item 2. PROPERTIES

The Company owns the facilities that its headquarters and R&D Systems subsidiary occupy in Minneapolis, Minnesota. The Minneapolis facilities are utilized by both the Company's Protein Sciences and Diagnostics and Genomics segments.

The Minneapolis complex includes approximately 800,000 square feet of space in several adjoining buildings. Bio-Techne uses approximately 625,000 square feet of the complex for administrative, research, manufacturing, shipping and warehousing activities. The Company is currently leasing the remaining space in the complex as retail and office space.

The Company owns a 17,000 square foot facility that its Bio-Techne Europe subsidiary occupies in Abingdon, England. This facility is utilized by the Company's Protein Sciences and Diagnostics and Genomics segments.

Additionally, the Company owns a 34,000 square foot facility that its Atlanta Biologicals subsidiary occupies in Flowery Branch, Georgia. This facility is utilized by the Company’s Protein Sciences.

The Company leases the following material facilities, all of which are primarily utilized by the Company's Protein Sciences segment with the exception of the locations used by the Company's ProteinSimple and CyVek subsidiaries, which support both the Protein Sciences segment and the Diagnostics & Genomics segment). Certain locations are not named because they were not significant individually or in the aggregate as of the date of this report.

SubsidiaryLocationTypeSquare Feet
Bio-Techne EuropeLangley, United KingdomWarehouse14,300
Bio-Techne ChinaShanghai and Beijing, ChinaOffice/warehouse10,700
Boston BiochemCambridge, MassachusettsOffice/lab7,400
TocrisBristol, United KingdomOffice/manufacturing/lab/warehouse30,000
PrimeGeneShanghai, ChinaOffice/manufacturing/lab20,600
BionosticsDevens, MassachusettsOffice/manufacturing48,000
Novus BiologicalsLittleton, ColoradoOffice/warehouse22,500
ProteinSimpleSan Jose, CaliforniaOffice/manufacturing/warehouse167,000
ProteinSimple CanadaOttawa and Toronto, CanadaOffice/manufacturing/warehouse13,900
CyVekWallingford, ConnecticutOffice/manufacturing/warehouse17,500
CliniqaSan Marcos, CaliforniaOffice/manufacturing/warehouse62,200
Advanced Cell DiagnosticsNewark, CaliforniaOffice/manufacturing/warehouse46,500
Eurocell DiagnosticsRennes, FranceOffice/warehouse11,000
Exosome DiagnosticsWaltham, MassachusettsOffice/manufacturing/warehouse28,000

The Company believes the owned and leased properties are adequate to meet its occupancy needs in the foreseeable future.

Previous: Item 1B. UNRESOLVED STAFF COMMENTS · Next: Item 3. LEGAL PROCEEDINGS